Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Excess androgens may cause PCOS, not just be a symptom.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Baicalin may help reduce excessive male hormone levels in PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Finasteride does not prevent bladder cancer.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.